Yipinhong Pharmaceutical Co Ltd Class A (300723.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE1000035J7

Price
28.92 CNY
Market cap
13.06 bn CNY
P/E (2025)
–
P/S (2025)
14.01
Dividend yield
0.00 %
Net margin
-36.23 %
Return on equity (ROE)
-24.67 %
Return on assets (ROA)
-8.36 %

Yipinhong Pharmaceutical Co Ltd Class A financials

Fiscal year20242025
Revenue1.45 bn CNY932.27 m CNY
Gross profit874.02 m CNY526.52 m CNY
Operating income-370.71 m CNY-250.16 m CNY
EBIT-293.44 m CNY-311.66 m CNY
Net income-540.04 m CNY-337.79 m CNY
Diluted EPS – continuing operations-1.20 CNY-0.75 CNY

Full history since 2013, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Yipinhong Pharmaceutical Co Ltd Class A

ApicHope Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers pediatric medicines; chronic disease drugs; active pharmaceutical ingredients and formulations; and specialty traditional Chinese medicines. It is also involved in scientific research and technical services; wholesale and retail trade; information technology; and technology promotion and application services. The company was formerly known as ApicHope Pharmaceutical Co., Ltd and changed its name to ApicHope Pharmaceutical Group Co., Ltd. in December 2024. ApicHope Pharmaceutical Group Co., Ltd. was founded in 2002 and is headquartered in Guangzhou, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.